Tumour necrosis factor and anti-tumour necrosis factor approach to inflammatory demyelinating diseases of the central nervous systemSELMAJ, Krzysztof W.Annals of the rheumatic diseases. 2000, Vol 59, pp i94-i102, issn 0003-4967, SUP1Article

TNF-induced death of adult human oligodendrocytes is mediated by c-jun NH₂-terminal kinase-3JUREWICZ, Anna; MATYSIAK, Mariola; TYBOR, Krzysztof et al.Brain. 2003, Vol 126, pp 1358-1370, issn 0006-8950, 13 p., 6Article

MTR discloses subtle changes in the normal-appearing tissue from relatives of patients with MSSIGER-ZAJDEL, Malgorzata; FILIPPI, Massimo; SELMAJ, Krzysztof et al.Neurology. 2002, Vol 58, Num 2, pp 317-320, issn 0028-3878Article

TRAIL-induced death of human adult oligodendrocytes is mediated by JNK pathwayJUREWICZ, Anna; MATYSIAK, Mariola; ANDRZEJAK, Stanislaw et al.Glia (New York, NY. Print). 2006, Vol 53, Num 2, pp 158-166, issn 0894-1491, 9 p.Article

Hypoglycemia as a trigger for the syndrome of acute bilateral basal ganglia lesions in uremiaJURYNCZYK, Maciej; ROZNIECKI, Jacek; ZALESKI, Krzysztof et al.Journal of the neurological sciences. 2010, Vol 297, Num 1-2, pp 74-75, issn 0022-510X, 2 p.Article

Proton magnetic resonance spectroscopy of normal appearing white matter in familial and sporadic multiple sclerosisSIGER-ZAJDEL, Małgorzata; SELMAJ, Krzysztof W.Journal of neurology. 2005, Vol 252, Num 7, pp 830-832, issn 0340-5354, 3 p.Article

TRAIL induces death of human oligodendrocytes isolated from adult brainMATYSIAK, Mariola; JUREWICZ, Anna; JASKOLSKI, Dariusz et al.Brain. 2002, Vol 125, pp 2469-2480, issn 0006-8950, 12 p., 11Article

Soluble Nogo-A, an inhibitor of axonal regeneration, as a biomarker for multiple sclerosisJUREWICZ, Anna; MATYSIAK, Mariola; RAINE, Cedric S et al.Neurology. 2007, Vol 68, Num 4, pp 283-287, issn 0028-3878, 5 p.Article

Tumour necrosis factor-induced death of adult human oligodendrocytes is mediated by apoptosis inducing factorJUREWICZ, Anna; MATYSIAK, Mariola; TYBOR, Krzysztof et al.Brain. 2005, Vol 128, pp 2675-2688, issn 0006-8950, 14 p., 11Article

cDNA microarray analysis in multiple sclerosis lesions: detection of genes associated with disease activityMYCKO, Marcin P; PAPOIAN, Ruben; BOSCHEN, Ursula et al.Brain. 2003, Vol 126, pp 1048-1057, issn 0006-8950, 10 p., 5Article

Optical coherence tomography in multiple sclerosis : Thickness of the retinal nerve fiber layer as a potential measure of axonal loss and brain atrophySIGER, Malgorzata; DZIGIELEWSKI, Krzysztof; JASEK, Lukasz et al.Journal of neurology. 2008, Vol 255, Num 10, pp 1555-1560, issn 0340-5354, 6 p.Article

Immune Regulation of Multiple Sclerosis by Transdermally Applied Myelin PeptidesJURYNCZYK, Maciej; WALCZAK, Agata; JUREWICZ, Anna et al.Annals of neurology. 2010, Vol 68, Num 5, pp 593-601, issn 0364-5134, 9 p.Article

Discontinuation of interferon beta therapy in multiple sclerosis patients with high pre-treatment disease activity leads to prompt return to previous disease activitySIGER, Małgorzata; DURKO, Agnieszka; NICPAN, Agnieszka et al.Journal of the neurological sciences. 2011, Vol 303, Num 1-2, pp 50-52, issn 0022-510X, 3 p.Article

Differential prevention of experimental autoimmune encephalomyelitis with antigen-specific DNA vaccinationWALCZAK, Agata; SZYMANSKA, Bozena; SELMAJ, Krzysztof et al.Clinical neurology and neurosurgery. 2004, Vol 106, Num 3, pp 241-245, issn 0303-8467, 5 p.Conference Paper

Experimental autoimmune encephalomyelitis: CC chemokine receptor expression by trafficking cellsGLABINSKI, Andrzej R; BIELECKI, Bartosz; O'BRYANT, Sage et al.Journal of autoimmunity (Print). 2002, Vol 19, Num 4, pp 175-181, issn 0896-8411, 7 p.Article

Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple SclerosisGOLD, Ralf; KAPPOS, Ludwig; DAWSON, Katherine T et al.The New England journal of medicine. 2012, Vol 367, Num 12, pp 1098-1107, issn 0028-4793, 10 p.Article

Phase 2 Trial of a DNA Vaccine Encoding Myelin Basic Protein for Multiple SclerosisGARREN, Hideki; ROBINSON, William H; GIANETTONI, Jill et al.Annals of neurology. 2008, Vol 63, Num 5, pp 611-620, issn 0364-5134, 10 p.Article

Impaired maturation and altered regulatory function of plasmacytoid dendritic cells in multiple sclerosisSTASIOLEK, Mariusz; BAYAS, Antonios; KRUSE, Niels et al.Brain. 2006, Vol 129, pp 1293-1305, issn 0006-8950, 13 p., 5Article

Treatment with soluble tumor necrosis factor receptor (sTNFR):Fc/p80 fusion protein ameliorates relapsing-remitting experimental autoimmune encephalomyelitis and decreases chemokine expressionGLABINSKI, Andrzej R; BIELECKI, Bartosz; KAWCZAK, Julie A et al.Autoimmunity (Print). 2004, Vol 37, Num 6-7, pp 465-471, issn 0891-6934, 7 p.Article

Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECT): a randomised, double-blind, placebo-controlled trialGOLD, Ralf; GIOVANNONI, Gavin; ELKINS, Jacob et al.Lancet (British edition). 2013, Vol 381, Num 9884, pp 2167-2175, issn 0140-6736, 9 p.Article

A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple SclerosisKAPPOS, Ludwig; RADUE, Ernst-Wilhelm; BURTIN, Pascale et al.The New England journal of medicine. 2010, Vol 362, Num 5, pp 387-401, issn 0028-4793, 15 p.Article

Subgroups of the BENEFIT study : Risk of developing MS and treatment effect of interferon beta-1bPOLMAN, Chris H; KAPPOS, Ludwig; DAHMS, Susanne et al.Journal of neurology. 2008, Vol 255, Num 4, pp 480-487, issn 0340-5354, 8 p.Article

Quality of life outcomes with BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: The DEFINE studyKAPPOS, Ludwig; GOLD, Ralf; SEIDMAN, Emily et al.Multiple sclerosis. 2014, Vol 20, Num 2, pp 243-252, issn 1352-4585, 10 p.Article

Improvement in disability after alemtuzumab treatment of multiple sclerosis is associated with neuroprotective autoimmunityJONES, Joanne L; ANDERSON, Jane M; WEBBER, Daniel J et al.Brain. 2010, Vol 133, pp 2232-2247, issn 0006-8950, 16 p., 8Article

Overcoming failure to repair demyelination in EAE : γ-secretase inhibition of Notch signalingJURYNCZYK, Maciej; JUREWICZ, Anna; BIELECKI, Bartosz et al.Journal of the neurological sciences. 2008, Vol 265, Num 1-2, pp 5-11, issn 0022-510X, 7 p.Conference Paper